Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Serša Gregor) .

41 - 50 / 126
First pagePrevious page12345678910Next pageLast page
41.
In vivo electroporation of the urinary bladder in mice
Peter Veranič, Kristijan Jezernik, Maja Čemažar, Gregor Serša, 1998, original scientific article

Published in DiRROS: 19.01.2024; Views: 176; Downloads: 44
.pdf Full text (556,60 KB)

42.
Vinblastine increases antitumor effectiveness of bleomycin
Maja Čemažar, Marija Auersperg, Gregor Serša, 1997, original scientific article

Abstract: In our previous vinblastine (VELBE) was shown to increase the plasma membrane fluidity. This effect of VELBE might be expolited for better transport of drugs through the plasma membrane. Bleomycin (BLM) is a highly cytotoxic drug when present inside the cells but has a hampered transport through the plasma membrane. The aim of the present study was to determine whether pretreatment with VELBE can increase the effect of BLM on intraperitoneal SA-1 tumors in mice. BLM and VELBE were used as single agents or in various combinations, i.e. VELBE and BLM injected simultanously, BLM injected 24 h before VELBE or VELBE injected 24 h before BLM. Mice survival was the end-point used for determining the effect of this combined treatments. VELBE and BLM as a single treatment significantly prolonged median survival time of study animals compared to controls. Furthermore, when VELBE and BLM were combined, all threetested combinations were more effective than VELBE or BLM as single treatments. The effect on animal survival was equal when VELBE was given 24 h after or simultanously with BLM. The longest survival, however was obtained when VELBE was injected 24 h before BLM. From these results we can conclude that the underlying mechanisms for more than additive effect of VELBE and BLM when VELBE was given 24 h before BLM could be attributed to an increased membrane fluidity, possibly in combination with a cell kinetic effect.
Published in DiRROS: 18.01.2024; Views: 161; Downloads: 37
.pdf Full text (1,28 MB)

43.
44.
Seventh international symposium on neutron capture therapy for cancer
Gregor Serša, Janez Škrk, 1996, other component parts

Published in DiRROS: 16.01.2024; Views: 213; Downloads: 40
.pdf Full text (108,08 KB)

45.
46.
47.
Combined treatment of murine SA-1 tumors by human leukocyte interferon alpha and electrotherapy
Gregor Serša, Damijan Miklavčič, 1993, original scientific article

Keywords: rak (medicina), zdravljenje, elektroterapija, interferon
Published in DiRROS: 10.01.2024; Views: 190; Downloads: 42
.pdf Full text (454,89 KB)

48.
49.
Serum TNF-alpha levels in melanoma-bearing and healthy mice
Breda Kus, Gregor Serša, Srdjan Novaković, Anton Štalc, 1992, original scientific article

Published in DiRROS: 09.01.2024; Views: 173; Downloads: 47
.pdf Full text (377,92 KB)

50.
Search done in 0.36 sec.
Back to top